Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2025-12-26 @ 4:55 AM
Study NCT ID:
NCT00798161
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2008-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-11-24
First Submit QC Date:
None
Study First Post Date:
2008-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-20
Results First Submit QC Date:
None
Results First Post Date:
2011-08-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-11
Last Update Post Date:
2014-01-28
Last Update Post Date Type:
ESTIMATED